ClinicalTrials.gov
public full text
Public Domain
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia
The purpose of this study is to document the long term safety of a long-acting injectable formulation of risperidone in the treatment of patients with schizophrenia who have previously been treated with long-acting risperidone. Efficacy will also be evaluated.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients#1047410
- A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia#1008402
- Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia#1074439
- Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone#867295
- A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.#905449
Record · ID 882933
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive